Patient FAQs | Eversense CGM

Your Questions, Answered

We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.

Filter by topic:

Eversense^® E3 is not indicated for use in children.

Eversense^® E3 is a continuous glucose monitoring system indicated for the management of diabetes in adults age 18 years and older.

Non-clinical testing has demonstrated the Eversense^® E3 Sensor is MR Conditional. A patient with this device can be safely scanned in an MR system meeting the following conditions:

Static magnetic field of 1.5T or 3.0T
Maximum spatial field gradient of 2000 gauss/cm (20 T/m).
Maximum MR system reported, whole body averaged specific absorption rate (SAR) of 4 W/kg (First Level Controlled Operating Mode).

Under the scan conditions defined above, non-clinical testing results indicate the Eversense Sensor is expected to produce a maximum temperature rise of less than 5.4 °C after 15 minutes of continuous scanning.

In non-clinical testing, the image artifact caused by the device extends approximately 2.83 inches (72 mm) from the Eversense^® E3 Sensor when imaged with a gradient echo pulse sequence and a 3T MR system.

The Eversense Smart Transmitter is MR Unsafe and MUST BE REMOVED before undergoing an MRI procedure. Before you undergo an MRI procedure, tell the MRI staff that you have an Eversense Sensor and Smart Transmitter.

When traveling, your smart transmitter and sensor are safe to go through airport security without removing them. You may inform security that you have an implanted medical device.

Your smart transmitter will automatically sync to your smartphone’s current time and date when time zones are changed. You should allow for automatic syncing or manually change the time zone (not the time) if needed.

The Eversense^® E3 CGM System is safe for use on U.S. commercial airlines. The Eversense^® E3 Smart Transmitter is a Medical Portable Electronic Device (M-PED) with emission levels that meet FAA mandates for use in all modes while in flight. (Reference FAA Advisory, Circular #21-16G, dated 6.22.2011.) To use, turn your mobile device’s Bluetooth^® feature on after you have put your mobile device in airplane mode. For flights outside the US, follow local security regulations for use of medical devices in flight.

It is safe for you to wear your sensor and smart transmitter when you go through metal detectors at airports. While flying, the smart transmitter performs similar to any other Bluetooth^® device. Be sure to follow the specific safety guidelines mandated by the airline.

Still have questions?

The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.

The Eversense^® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense^® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied. 

Apple Watch^® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

MKT-001692 Rev 1

Your Questions, Answered

Still have questions?

Pre-Qualify for Eversense 365

Thanks! We've got your info. You may be eligible for Eversense 365

Thanks! We've got your info.

I'M JUST RESEARCHING

I'M READY NOW!

Contact Information

Preferred Language

Your Questions, Answered

Is Eversense® E3 safe for use in children?

MRI Safety Information

Is it safe to use Eversense® during air travel?

Is it safe to wear the Eversense E3 Sensor and Smart Transmitter through a metal detector or airport security?

Still have questions?

I'M JUST RESEARCHING

I'M READY NOW!